Previous Article | Next Article ![]()
Infect Immun. 1971 February; 3(2): 328-332
Copyright © 1971 American Society for Microbiology. All Rights Reserved.
Microbiology Division, U.S. Army Medical Research and Nutrition Laboratory, Fitzsimons General Hospital, Denver, Colorado 80240
ABSTRACT
L-Homoserine was observed to inhibit the growth of Mycobacterium tuberculosis. In the metabolism of M. tuberculosis, L-homoserine was found to be a precursor of threonine, isoleucine, and methionine. L-Homoserine-inhibited cells contained elevated levels of the enzyme acetohydroxy acid synthetase. In addition, washed cell suspensions of M. tuberculosis formed significant amounts of alpha-amino-n-butyric acid from supplements of L-homoserine. DL-Alpha-amino-n-butyric acid proved to be much more inhibitory for growth than L-homoserine. Growth antagonism by L-homoserine was reversed by L-lysine, L-threonine, and combinations of L-leucine with L-valine. At the cellular level, these amino acids reduced the amount of acetohydroxy acid synthetase in cells grown with L-homoserine and competed with DL-homoserine-4-14C for entrance into the extractable cell pool. L-Isoleucine also antagonized the conversion of L-homoserine to alpha-amino-n-butyric acid. Available data indicated that the effect of L-homoserine was related to its conversion to alpha-amino-n-butyric acid which subsequently inhibited growth
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|